Bladex, Inc. (Banco Latinoamericano de Comercio Exterior, S.A.) — 2019 Form 20-F
Reporting period: Fiscal year ended December 31, 2019. This is an annual report, not a standalone fourth-quarter filing; the supplied text does not provide clear Q4-only financial results. Financial statements are consolidated, prepared under IFRS, and presented in U.S. dollars.
Business context
Bladex is a Panama-based multinational bank focused on trade finance and regional integration in Latin America and the Caribbean. Its two segments are Commercial, its lending and fee-generation business, and Treasury, which manages liquidity, funding, investments and balance-sheet risks. It does not take retail deposits.
Key financial results and position
| Metric | 2019 | 2018 |
|---|---|---|
| Total revenue | $126.7 million | $127.6 million |
| Net interest income | $109.5 million | $109.7 million |
| Net interest margin / spread | 1.74% / 1.19% | 1.71% / 1.21% |
| Profit / diluted EPS | $86.1 million / $2.17 | $11.1 million / $0.28 |
| Return on average equity / assets | 8.56% / 1.36% | 1.08% / 0.17% |
| Operating expenses / efficiency ratio | $40.7 million / 32.1% | $48.9 million / 38.3% |
| Total assets / total equity | $7.25 billion / $1.02 billion | $7.61 billion / $994 million |
| Deposits / borrowings and debt, net | $2.89 billion / $3.14 billion | $2.97 billion / $3.52 billion |
- Balance sheet and lending: Gross loans were $5.89 billion, up 2%; the Commercial Portfolio was $6.50 billion, up 3%. Total assets declined 5%, principally as year-end cash and bank balances normalized from unusually high 2018 levels.
- Liquidity: Cash and cash equivalents were $1.16 billion, down from $1.71 billion. Liquid assets equaled 16% of assets and 40% of deposits, versus 22% and 57% in 2018. The Bank reported a 131% regulatory LCR, above its 25% minimum for 2019.
- Cash flow: Net cash used in operating activities was $92.4 million, mainly reflecting loan growth; investing activities provided $31.1 million; financing activities used $485.1 million, including net repayment of short-term funding and dividends.
- Capital: Basel III Tier 1 capital ratio was 19.8%, versus 18.1%; equity/assets was 14.02%, versus 13.06%; leverage was 7.1x, versus 7.7x. The filing also reports a separate Panamanian-law primary-capital-to-risk-weighted-assets ratio of 17.3%.
- Credit quality: Credit-impaired loans were $62 million, or 1.05% of gross loans, versus $65 million, or 1.12%. The allowance for loan losses was $99.3 million; total credit allowances, including commitments and guarantees, were $102.4 million, or 1.57% of the Commercial Portfolio. The impaired balance was concentrated in one Brazilian sugar-sector borrower, with an individually assigned allowance of $54 million (88% coverage). Watch-list potential problem loans increased to $91.3 million, or 1.6% of loans, from $53.4 million.
- Shareholder return: 2019 dividends paid were $1.54 per share. The Board subsequently reduced the first-quarter 2020 dividend to $0.25 per share from $0.385 as a precaution under market conditions.
Material changes versus 2018
- Profit rebounded to $86.1 million primarily because financial-instrument impairment losses fell to $0.4 million from $57.5 million in 2018. The prior-year charge largely reflected deterioration and restructuring risk in the Brazilian sugar exposure. In 2019, there were no new loans classified as credit-impaired since the third quarter of 2018.
- Operating expenses fell 17%, aided by lower employee costs following 2018 restructuring, cost controls, and the absence of certain prior-year one-time charges. The 2019 result also included IFRS 16 lease accounting, adopted from January 1, 2019.
- Revenue was broadly stable, but net interest income was slightly lower. Higher market rates lifted lending yields, while higher funding costs and lower average lending volumes offset much of the benefit. Average funding cost rose to 3.10% from 2.76%.
- The loan portfolio shifted toward longer maturities: 71% of loans were due within one year, versus 73% in 2018. Country exposures also shifted, including lower Argentina exposure and higher Colombia and Chile exposure.
- Operating cash use narrowed from $173.6 million in 2018. Financing cash flow changed from a $1.28 billion inflow in 2018 to a $485.1 million outflow in 2019, largely reflecting repayment of short-term borrowings and debt.
Outlook, risks and unusual items
- COVID-19: The filing describes the pandemic’s potentially material effects on borrowers, credit losses, lending and transaction volumes, funding access and operating conditions. By March 2020, Bladex had activated remote-work continuity arrangements, increased liquidity, and tightened underwriting. It said collections on scheduled maturities had allowed it to lend selectively and reduce the loan portfolio; the ultimate impact remained uncertain and could not be reliably quantified.
- Management priorities: During the pandemic, management prioritized credit soundness, liquidity and transaction-level risk/return over portfolio growth. Longer-term stated priorities include improving operating efficiency, focusing on stable and growth-oriented markets, diversifying country and industry exposure, and broadening products and services. No numerical earnings or revenue guidance is provided.
- Regional and portfolio risks: The Bank reported substantial exposure to a small group of countries: 59% of the Credit Portfolio was in Brazil, Colombia, Mexico, Chile and Ecuador. Commodity, political, trade and economic shocks may affect borrowers; oil and gas represented 10% and agribusiness 6% of the Loan Portfolio.
- Funding and ratings: Funding depends on deposits and international bank borrowing. Central banks or designees accounted for 61% of deposits at year-end, and the five largest depositors represented 49%. Fitch, Moody’s and S&P ratings were investment grade but each had a negative outlook as of the filing.
- Other risks and contingencies: The filing identifies interest-rate and benchmark-transition risk (including LIBOR), sanctions and regulatory compliance, cybersecurity and operational risk, competition, and the possibility that credit-loss allowances prove inadequate. Off-balance-sheet commitments and guarantees totaled $493.4 million; management noted that contractual amounts do not necessarily represent future funding needs. The Bank reported no significant pending litigation and compliance with debt covenants at year-end.
- Accounting and audit: IFRS 16 adoption recognized $17.4 million of right-of-use assets and $21.0 million of lease liabilities at transition, with a $1.9 million reduction to retained earnings. KPMG issued unqualified opinions on the 2019 financial statements and internal control over financial reporting; management also concluded disclosure controls and financial-reporting controls were effective.
Most important facts for investors to verify
- How COVID-19 subsequently affected loan balances, impaired and watch-list exposures, provisions, collections and borrower restructurings—especially the single Brazilian sugar-sector exposure.
- Whether liquidity and funding remained adequate as deposits, short-term borrowings, market access and funding costs changed; review depositor concentration and negative credit-rating outlooks.
- Whether 2019’s profit rebound is sustainable, given that the sharp improvement was largely driven by much lower impairment charges, while revenue was slightly lower and funding costs rose.
- Whether the reduced 2020 dividend and selective underwriting persisted, and how they affected earnings, capital and shareholder returns.
- Reconcile the filing’s distinct capital-ratio measures and cash-flow presentations against the audited statements and regulatory disclosures.